SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000893838-05-000129
Filing Date
2005-05-17
Accepted
2005-05-17 21:58:03
Documents
2
Period of Report
2005-05-13

Document Format Files

Seq Description Document Type Size
1 rexahnfrm3rexgene051605_ex.html 3  
1 rexahnfrm3rexgene051605_ex.xml 3 2718
2 poarexgene.txt EX-24 2355
  Complete submission text file 0000893838-05-000129.txt   7187
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 401 WOOYOUNG VENTURE BLDG. SEOCHO-DONG SEOCHO-GU SEOUL M5 1330-13
Business Address 401 WOOYOUNG VENTURE BLDG. SEOCHO-DONG SEOCHO-GU SEOUL M5 1330-13 82-2 587 0019
Rexgene Biotech Co., Ltd. (Reporting) CIK: 0001316425 (see all company filings)

State of Incorp.: M5 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-50590 | Film No.: 05840156